Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Hardin · SciRah

Researcher profile · Semantic Scholar

M. Hardin

Share profile

M. Hardin — researcher profile on SciRah

h-index: 3
Works: 30
Citations: 118

Most-cited papers

Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents
J. Wheless, P. Gibson, K. L. Rosbeck, M. Hardin +3 more
2012BMC Pediatrics65 citations Open access
Semantic Scholar
Basic neural processing of sound in adults is influenced by bilingual experience.
E. Skoe, Emily Burakiewicz, M. Figueiredo, M. Hardin
2017Neuroscience35 citations
Semantic Scholar
FeNO as a Potential Prognostic and Predictive Marker of Lung Function Decline in Patients with Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA QUEST
I. Pavord, G. Brusselle, D. Jackson, C. Brightling +10 more
2022B93. BREAKTHROUGHS IN PEDIATRIC AND ADULT ASTHMA CLINICAL TRIALS7 citations
Semantic Scholar
P38 Dupilumab Improves Quality of Life in Caregivers of Children with Uncontrolled Moderate-to-Severe Asthma: Liberty Asthma Voyage Study
A. Fiocchi, W. Phipatanakul, S. Durrani, J. Cole +5 more
2022Value in Health2 citations Open access
Semantic Scholar
Biomarkers associated with lung function decline and dupilumab response in patients with moderate-to-severe asthma
I. Pavord, G. Brusselle, D. Jackson, C. Brightling +10 more
202205.03 - Allergy and immunology2 citations
Semantic Scholar
Dupilumab Efficacy and Safety in Children with Uncontrolled, Moderate-to-Severe Asthma: The Phase 3 VOYAGE Study
L. Bacharier, J. Máspero, C. Katelaris, A. Fiocchi +18 more
D7. D007 ADVANCES IN ASTHMA THERAPIES2 citations Open access
Semantic Scholar
Continuous associations of type 2 biomarkers and efficacy of dupilumab in children with uncontrolled, moderate-to-severe asthma
L. Bacharier, D. Jackson, I. Pavord, J. Máspero +10 more
202207.02 - Paediatric asthma and allergy1 citations
Semantic Scholar
CO87 Reductions in Exacerbations and Improvements in Lung Function and Asthma Control in Children With Moderate-to-Severe Type 2 Asthma Analyzed by High- or Medium-Dose of Inhaled Corticosteroids at Baseline
J. Máspero, M. Antila, N. Jain, A. Deschildre +10 more
2022Value in Health1 citations
Semantic Scholar
P068 DUPILUMAB REDUCES BIOMARKERS OF TYPE 2 INFLAMMATION IN CHILDREN WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA
L. Bacharier, J. Máspero, C. Katelaris, A. Fiocchi +3 more
2021Annals of Allergy, Asthma & Immunology1 citations
Semantic Scholar
Assessment of Long-Term Maintenance of OCS Reduction and Efficacy in the Dupilumab LIBERTY ASTHMA TRAVERSE Extension Study
L. Sher, M. Wechsler, K. Rabe, J. Máspero +9 more
20211 citations
Semantic Scholar
P48 Long-term efficacy of dupilumab in patients with moderate-to-severe asthma in the LIBERTY ASTHMA TRAVERSE open-label extension study: improvements in asthma control and health-related quality of life
I. Pavord, M. Wechsler, L. Ford, Jf Maspero +10 more
2021Diagnostics and monitoring of asthma and co-morbidities1 citations Open access
Semantic Scholar
Dupilumab Add-on to Medium-dose Inhaled Corticosteroid (ICS) Increases Odds of Asthma Control and Reduces FeNO Compared With Placebo Add-on to High-dose ICS
W. Busse, M. Castro, N. Lugogo, P. O'Byrne +8 more
2024C34. BIOLOGIC THERAPY IN THE FIGHT AGAINST ASTHMA AND ALLERGIC INFLAMMATION0 citations
Semantic Scholar
CO174 Baseline Characteristics of Patients with Asthma and Prior Oral Systemic Corticosteroid Use Initiating Dupilumab in a Real-World Registry (RAPID)
N. Lugogo, E. Heffler, V. Plaza, O. Hilberg +10 more
2024Value in Health0 citations
Semantic Scholar
Comparative Effectiveness of Dupilumab Versus Omalizumab in Asthma Among Biologic-Naïve Patients: Findings From the Real-World US Advantage Study
E. Bleecker, M. Blaiss, J. Jacob-Nara, L. Huynh +6 more
2023C101. IMPACT OF BIOLOGICS ON ASTHMA OUTCOMES0 citations
Semantic Scholar
PCR200 Characteristics at Baseline of Patients with Asthma and Prior Systemic Corticosteroid Use Initiating Dupilumab Enrolled in the Real-World Study Rapid
N. Lugogo, E. Heffler, V. Plaza, O. Hilberg +10 more
2023Value in Health0 citations
Semantic Scholar
Real-world Effectiveness of Dupilumab in Biologic Naïve Patients With Asthma: Analysis From the US Advantage Study
R. Stanford, M. Blaiss, E. Bleecker, J. Jacob-Nara +6 more
2023World0 citations
Semantic Scholar
Long-term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: The Liberty Asthma Traverse Continuation Study
J. Máspero, A. Peters, K. Chapman, C. Domingo +11 more
2023World0 citations
Semantic Scholar
Dupilumab Improved Long-term Lung Function in Children Aged 6 to 11 Years With Moderate-to-Severe Asthma: Liberty Asthma Excursion
L. Bacharier, J. Máspero, C. Katelaris, A. Fiocchi +15 more
2023C101. IMPACT OF BIOLOGICS ON ASTHMA OUTCOMES0 citations
Semantic Scholar
PCR69 Sustained Improvement in Asthma Control with Dupilumab Treatment in Patients with Uncontrolled, Moderate-to-Severe Type 2 Asthma: Post Hoc Analysis of Liberty Asthma Traverse Open-Label Extension Study
W. Busse, I. Pavord, J. Corren, A. Menzies-Gow +10 more
2022Value in Health0 citations Open access
Semantic Scholar
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma with Elevated Type 2 Biomarkers and Fixed Airflow Obstruction
N. A. Hanania, M. Castro, E. Bateman, I. Pavord +15 more
2022C101. EXPANDING THE USE OF ASTHMA BIOLOGICS AND OTHER NOVEL THERAPEUTICS TO ADDITIONAL PATIENT POPULATIONS0 citations
Semantic Scholar
Dupilumab efficacy in children with uncontrolled type 2 asthma with baseline high/medium ICS dose
J. Máspero, M. Antila, N. Jain, A. Deschildre +10 more
202207.02 - Paediatric asthma and allergy0 citations
Semantic Scholar
Pharmacokinetics and Effect on Type 2 Biomarker Levels of Dupilumab Weight Tiered-Based Dose Regimens in Patients Aged 6 to 11 Years with Uncontrolled, Moderate-to-Severe Asthma
D. Jackson, L. Bacharier, L. Sher, C. D. Ribas +17 more
2022C101. EXPANDING THE USE OF ASTHMA BIOLOGICS AND OTHER NOVEL THERAPEUTICS TO ADDITIONAL PATIENT POPULATIONS0 citations
Semantic Scholar
S126 Dupilumab efficacy in children with uncontrolled type 2 asthma analyzed by baseline high or medium ICS dose: LIBERTY ASTHMA VOYAGE study
Jf Maspero, M. Antila, N. Jean, A. Deschildre +11 more
2022‘Finding Neverland’ – T2 inflammation and its absence0 citations
Semantic Scholar
Dupilumab Impact on Lung Function in Children with Uncontrolled, Moderate-To-Severe Asthma and Elevated Type 2 Biomarkers
T. W. Guilbert, L. Bacharier, A. Deschildre, W. Phipatanakul +11 more
2022B93. BREAKTHROUGHS IN PEDIATRIC AND ADULT ASTHMA CLINICAL TRIALS0 citations
Semantic Scholar
Effect of dupilumab on asthma control and asthma-related quality of life in patients with uncontrolled, moderate-to-severe type 2 asthma: TRAVERSE OLE study
W. Busse, I. Pavord, J. Corren, A. Menzies-Gow +10 more
202205.03 - Allergy and immunology0 citations
Semantic Scholar
Dupilumab Asthma ADVANTAGE-US: Characterization of a Large Cohort of Adolescent and Adult Patients with Asthma Initiating Dupilumab in a US-based Electronic Medical Record Database - Analysis of Real-World Evidence
L. Huynh, A. Nag, M. Hardin, K. Borsos +6 more
2022A34. TOPICS IN HEALTH SERVICES RESEARCH AND SELF-MANAGEMENT FOR PATIENTS WITH OBSTRUCTIVE LUNG DISEASE0 citations
Semantic Scholar
PBI1 Liberty Asthma Traverse Dupilumab Shows Sustained Efficacy and Improvements in Asthma Control and Health-Related Quality of Life (HRQOL) in Patients with Moderate-to-Severe Asthma
M. Wechsler, L. Ford, J. Máspero, I. Pavord +10 more
2021Value in Health0 citations Open access
Semantic Scholar
S84 Long-term efficacy of dupilumab: 3-year data of QUEST patients with moderate-to-severe asthma enrolled in LIBERTY ASTHMA TRAVERSE
I. Pavord, A. Papi, A. Bourdin, H. Watz +10 more
2021Biologics for asthma0 citations Open access
Semantic Scholar
Dupilumab Shows Sustained Efficacy and Improvements in Asthma Control and Health-Related Quality of Life in Patients with Moderate-to-Severe Asthma: LIBERTY ASTHMA TRAVERSE
M. Wechsler, L. Ford, J. Máspero, I. Pavord +10 more
20210 citations
Semantic Scholar
Long-Term Dupilumab Treatment in Moderate-to-Severe Asthma with Type 2 Inflammation: Open Label LIBERTY ASTHMA TRAVERSE Study
M. Wechsler, I. Pavord, A. Papi, K. Chapman +8 more
D7. D007 ADVANCES IN ASTHMA THERAPIES0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Y. Deniz×14
Invite
Y. Deniz — researcher profile on SciRah
P. Rowe×13
Invite
P. Rowe — researcher profile on SciRah
E. Laws×13
Invite
E. Laws — researcher profile on SciRah
J. Jacob-Nara×11
Invite
J. Jacob-Nara — researcher profile on SciRah

×10

Invite

J. Máspero — researcher profile on SciRah

Invite

A. Papi — researcher profile on SciRah

Invite

D. Lederer — researcher profile on SciRah

Invite

X. Mao — researcher profile on SciRah

Invite

N. Amin — researcher profile on SciRah

Invite

D. Lederer — researcher profile on SciRah

Invite

Y. Zhang — researcher profile on SciRah

L. Bacharier×7

Invite

L. Bacharier — researcher profile on SciRah